Dover Reports First Quarter 2025 Results
1. Dover's Q1 2025 revenue declined 1%, GAAP earnings down 60%. 2. Adjusted EPS increased 19% to $2.05, demonstrating underlying growth. 3. Solid demand noted in key segments, especially biopharma and CO2 systems. 4. Dover projects 2025 adjusted EPS between $9.20 and $9.40. 5. Management remains optimistic despite global market challenges.